iShares Global Healthcare ETF (NYSEARCA:IXJ – Get Free Report) saw a large growth in short interest during the month of June. As of June 15th, there was short interest totaling 148,762 shares, a growth of 181.9% from the May 31st total of 52,767 shares. Currently, 0.4% of the company’s stock are sold short. Based on an average daily trading volume, of 209,430 shares, the short-interest ratio is presently 0.7 days.
iShares Global Healthcare ETF Stock Down 0.8%
Shares of NYSEARCA IXJ traded down $0.84 during trading on Tuesday, reaching $98.66. The company had a trading volume of 327,425 shares, compared to its average volume of 303,869. iShares Global Healthcare ETF has a 12-month low of $82.16 and a 12-month high of $101.78. The business’s 50-day moving average is $93.94 and its 200 day moving average is $96.20. The stock has a market cap of $3.84 billion, a PE ratio of 21.58 and a beta of 0.58.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in IXJ. J. R. Prunier Capital Management LLC grew its holdings in shares of iShares Global Healthcare ETF by 7.3% during the first quarter. J. R. Prunier Capital Management LLC now owns 4,634 shares of the company’s stock valued at $433,000 after buying an additional 314 shares during the last quarter. Rathbones Group PLC raised its holdings in iShares Global Healthcare ETF by 1.1% in the 1st quarter. Rathbones Group PLC now owns 25,741 shares of the company’s stock worth $2,408,000 after acquiring an additional 280 shares during the last quarter. Ipsen Advisor Group LLC raised its holdings in iShares Global Healthcare ETF by 4.6% in the 1st quarter. Ipsen Advisor Group LLC now owns 13,215 shares of the company’s stock worth $1,236,000 after acquiring an additional 576 shares during the last quarter. Compass Capital Management Inc. bought a new position in iShares Global Healthcare ETF in the 1st quarter valued at approximately $449,000. Finally, Front Row Advisors LLC boosted its stake in iShares Global Healthcare ETF by 8.0% during the 1st quarter. Front Row Advisors LLC now owns 2,699 shares of the company’s stock valued at $252,000 after purchasing an additional 200 shares during the last quarter.
iShares Global Healthcare ETF Company Profile
iShares Global Healthcare ETF (the Fund), formerly iShares S&P Global Healthcare Sector Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the S&P Global 1200 Healthcare Sector Index (the Index). The Index measures the performance of companies that Standards & Poor’s Financial Services LLC (S&P) deems to be a part of the consumer staples sector of the economy. It is a subset of the S&P Global 1200 Index. Component companies include healthcare providers, biotechnology companies and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.
Featured Articles
- Five stocks we like better than iShares Global Healthcare ETF
- Rocket Lab Defies Gravity With $8B Buyout
- Even CEOs Need Cash: Insider Selling Is Not the Only Signal in AI Stocks
- The Quantum Bubble Is Real Enough to Take Seriously
- Why Wall Street Still Sees Massive Upside for AeroVironment Stock
Receive News & Ratings for iShares Global Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Global Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
